(in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $406.87 | $148.81 | $158.74 | $130.66 |
Short term investments | ||||
Net receivables | $732.68 | $790.33 | $751.53 | $720.25 |
Inventory | $510.03 | $540.18 | $545.6 | $527.94 |
Total current assets | $1717.08 | $1545.12 | $1523.56 | $1446.26 |
Long term investments | ||||
Property, plant & equipment | $474.23 | $473.67 | $484.67 | $485.33 |
Goodwill & intangible assets | $2116.44 | $2119.02 | $2145.84 | $2154.36 |
Total noncurrent assets | $2903.89 | $2868.84 | $2917.54 | $2915.87 |
Total investments | ||||
Total assets | $4620.97 | $4413.95 | $4441.1 | $4362.13 |
Current liabilities | ||||
Accounts payable | $243.83 | $213.66 | $233.6 | $207.57 |
Deferred revenue | $303.87 | $292.51 | $264.77 | $234.49 |
Short long term debt | ||||
Total current liabilities | $806.54 | $775.38 | $720.93 | $672.19 |
Long term debt | $1168.97 | $1168.03 | $1299.01 | $1353.64 |
Total noncurrent liabilities | $1486.01 | $1453.42 | $1581.91 | $1635.78 |
Total debt | $1168.97 | $1168.03 | $1299.01 | $1353.64 |
Total liabilities | $2292.56 | $2228.8 | $2302.83 | $2307.97 |
Shareholders' equity | ||||
Retained earnings | $3487.75 | $3375.5 | $3297.28 | $3223.94 |
Other shareholder equity | -$213.22 | -$253.42 | -$225.38 | -$244.44 |
Total shareholder equity | $2328.41 | $2185.16 | $2138.26 | $2054.16 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $406.87 | $256.97 | $171 | $198.25 |
Short term investments | ||||
Net receivables | $732.68 | $724.6 | $647.15 | $588.72 |
Inventory | $510.03 | $483.11 | $411.57 | $428.88 |
Total current assets | $1717.08 | $1517.31 | $1307.81 | $1300.82 |
Long term investments | ||||
Property, plant & equipment | $474.23 | $496.56 | $503.64 | $529.1 |
Goodwill & intangible assets | $2116.44 | $2165.53 | $2001.1 | $2064.77 |
Total noncurrent assets | $2903.89 | $2932.29 | $2795.74 | $2720.51 |
Total investments | ||||
Total assets | $4620.97 | $4449.6 | $4103.55 | $4021.33 |
Current liabilities | ||||
Accounts payable | $243.83 | $266.52 | $211.64 | $201.24 |
Deferred revenue | $303.87 | $242.48 | $260.16 | $253.41 |
Short long term debt | $202.5 | $100 | ||
Total current liabilities | $806.54 | $971.44 | $734.87 | $810.38 |
Long term debt | $1168.97 | $1059.82 | $1177.76 | $1091.36 |
Total noncurrent liabilities | $1486.01 | $1486.04 | $1542.19 | $1423.38 |
Total debt | $1168.97 | $1386.67 | $1177.76 | $1191.36 |
Total liabilities | $2292.56 | $2457.48 | $2277.05 | $2233.76 |
Shareholders' equity | ||||
Retained earnings | $3487.75 | $3174.4 | $2908.83 | $2670.33 |
Other shareholder equity | -$213.22 | -$258.92 | -$190.47 | -$310.86 |
Total shareholder equity | $2328.41 | $1992.12 | $1826.49 | $1787.57 |
(in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $724.33 | $704.4 | $630.86 | |
Cost of revenue | $442.86 | $444.82 | $409.45 | |
Gross Profit | $281.47 | $259.57 | $221.41 | |
Operating activities | ||||
Research & development | $23.46 | $20.21 | $22.02 | |
Selling, general & administrative | $125.48 | $126.59 | $120.77 | |
Total operating expenses | $148.95 | $146.8 | $142.79 | |
Operating income | $132.52 | $112.78 | $78.61 | |
Income from continuing operations | ||||
EBIT | $139.54 | $120.73 | $86.38 | |
Income tax expense | $30.27 | $24.74 | $16.59 | |
Interest expense | $12.5 | $14.99 | $12.94 | |
Net income | ||||
Net income | $96.78 | $81 | $56.85 | |
Income (for common shares) | $96.78 | $81 | $56.85 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $2845.37 | $2557.03 | $2505.93 | $2391.34 |
Cost of revenue | $1778.19 | $1602.42 | $1572.58 | $1550.11 |
Gross Profit | $1067.18 | $954.61 | $933.36 | $841.23 |
Operating activities | ||||
Research & development | $85.76 | $80.84 | $88.49 | $74.82 |
Selling, general & administrative | $496.81 | $445.68 | $443.1 | $412.82 |
Total operating expenses | $582.58 | $526.51 | $550.67 | $552.38 |
Operating income | $484.6 | $428.09 | $382.68 | $288.85 |
Income from continuing operations | ||||
EBIT | $514.46 | $436.18 | $394.75 | $298.6 |
Income tax expense | $108.56 | $94.85 | $87.35 | $61.66 |
Interest expense | $51.39 | $46.98 | $40.24 | $35.55 |
Net income | ||||
Net income | $354.51 | $294.35 | $267.16 | $201.39 |
Income (for common shares) | $354.51 | $294.35 | $267.16 | $201.39 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Net income | $119.89 | $96.78 | $81 | $56.85 |
Operating activities | ||||
Depreciation | $29.34 | $28.86 | $29.05 | $28.93 |
Business acquisitions & disposals | ||||
Stock-based compensation | $3.59 | $4.35 | $3.68 | $5.18 |
Total cash flows from operations | $282.37 | $146.36 | $110.95 | -$91.6 |
Investing activities | ||||
Capital expenditures | -$3.95 | -$9.38 | -$11.75 | -$10.44 |
Investments | ||||
Total cash flows from investing | -$3.95 | -$9.38 | -$11.75 | -$10.44 |
Financing activities | ||||
Dividends paid | -$15.3 | -$7.66 | -$7.29 | |
Sale and purchase of stock | -$12.77 | -$7.64 | -$11.98 | -$7.16 |
Net borrowings | -$125 | -$53.2 | -$24.3 | |
Total cash flows from financing | -$28.36 | -$140.58 | -$72.74 | -$31.73 |
Effect of exchange rate | $7.99 | -$6.33 | $1.62 | $7.45 |
Change in cash and equivalents | $258.06 | -$9.93 | $28.08 | -$126.31 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $354.51 | $294.35 | $267.16 | $201.39 |
Operating activities | ||||
Depreciation | $116.17 | $112.03 | $114.38 | $115.9 |
Business acquisitions & disposals | -$287.49 | -$5.34 | -$487.94 | |
Stock-based compensation | $16.8 | $15.38 | $13.45 | $14.44 |
Total cash flows from operations | $448.09 | $294.78 | $387.67 | $261.18 |
Investing activities | ||||
Capital expenditures | -$35.52 | -$28.38 | -$37.06 | -$44.57 |
Investments | -$10 | |||
Total cash flows from investing | -$35.52 | -$325.87 | -$42.4 | -$532.53 |
Financing activities | ||||
Dividends paid | -$30.25 | -$28.78 | -$28.66 | -$28.18 |
Sale and purchase of stock | -$39.56 | -$46.87 | -$333.42 | -$188.87 |
Net borrowings | -$202.5 | $206.1 | -$6.1 | $300 |
Total cash flows from financing | -$273.4 | $129.43 | -$369.13 | $82.08 |
Effect of exchange rate | $10.73 | -$12.37 | -$3.38 | -$3.52 |
Change in cash and equivalents | $149.89 | $85.97 | -$27.24 | -$192.78 |
Market cap | $9.49B |
---|---|
Enterprise value | $10.26B |
Shares outstanding | 38.20M |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | 3.74 |
Book/Share | 66.53 |
Cash/Share | 10.65 |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | 0.98 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 2.13 |
Quick ratio | 1.50 |